A randomized, double-blind, parallel group, phase II studyestimated the overall survival for two separate doses (250mg and500mg) of an anticancer agent developed for the treatment of lungcancer. The overall survival curves are attached.
Questions:
1. Which group had the best survival?
2. What was the median survival in each group?
Overall survval (normal N 8 8 Proportion event free 2 2 8 wo
A randomized, double-blind, parallel group, phase II study estimated the overall survival for two separate doses (250mg
-
- Site Admin
- Posts: 899603
- Joined: Mon Aug 02, 2021 8:13 am